Namilumab

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T76820-1mg	1 mg	-	-	-	7 - 10 business days*		233.00€
TGM-T76820-10mg	10 mg	-	-	-	7 - 10 business days*		1,137.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Namilumab (AMG203) is a humanised IgG1 monoclonal antibody that neutralises GM-CSF... more

Close menu

Product information "Namilumab"

Description: Namilumab (AMG203) is a humanised IgG1 monoclonal antibody that neutralises GM-CSF (granulocyte-macrophage colony-stimulating factor) by binding to its ligand with high affinity, and is used in the study of rheumatoid arthritis and active axial spondyloarthritis. Target: c-Fms. References: Huizinga TWJ, et, al. Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor monoclonal antibody, in mild-to-moderate rheumatoid arthritis. Arthritis Res Ther. 2017 Mar 9,19(1):53.